Michele's Feed
@peterlauria3 A little rich from Manhattan-centric titles like New Yorker, New York mag, New York Times. Cultural dominance is hard to lose
‘Cat ladies’ more likely to commit suicide, scientists claim via @Telegraph http://t.co/hyCqJapa
Explaining the pitfalls of “liquid candy” is no easy task http://t.co/zZbYG8TN
Like George Clooney running from the paparazzi: The Higgs particle – what it is and what it does http://t.co/Hy0OVP0B
“It is very much a smoking duck that walks and quacks like the Higgs.” http://t.co/hkvmp8GA
Bristol-Myers to buy Amylin for about $5.3 billion
NEW YORK (Reuters) – Bristol-Myers Squibb Co will buy biotechnology company Amylin Pharmaceuticals Inc for about $5.3 billion in cash, helping Bristol-Myers extend its portfolio of diabetes treatments with the addition of drugs Byetta and Bydureon.
Bristol-Myers said late on Friday it had also reached a follow-on deal with UK-based AstraZeneca Plc to collaborate on developing Amylin’s products once the buyout is completed, expanding upon an existing partnership between the two pharmaceutical makers in diabetes treatments. AstraZeneca will pay $3.4 billion in cash for these rights.
A little shout-out to my neighborhood pool, a gem of 1930s public works just reopened: http://t.co/7V4lj63F
After health ruling, will US be ready for the law? http://t.co/aIY5yMTm via @DMorganReuters
That wraps up our discussion on the Supreme Court ruling. A replay will be up later today at http://t.co/IhxcHuAV
Mariner: I worry about discussions with the deficit and costs of implementing ACA will mean chopping off many of the innovative program…
-
About Michele
-
Follow Michele
